These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention. Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008 [TBL] [Abstract][Full Text] [Related]
6. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Wickenbrock I; Perings C; Maagh P; Quack I; van Bracht M; Prull MW; Plehn G; Trappe HJ; Meissner A Clin Res Cardiol; 2009 Dec; 98(12):765-72. PubMed ID: 19851800 [TBL] [Abstract][Full Text] [Related]
7. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease. Ebisawa S; Kurita T; Tanaka N; Nasu K; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Terashima M; Suzuki T Cardiovasc Interv Ther; 2016 Jan; 31(1):13-20. PubMed ID: 26001976 [TBL] [Abstract][Full Text] [Related]
8. Contrast-induced Nephropathy Following Percutaneous Coronary Intervention at a Tertiary Cardiac Center in Nepal. Mandal A; Paudel MS; Kafle P; Khalid M; Bhattarai B; Kanth R; Maskey A; Lamicchane J; Ray NM; Sharma D; Gautam S; Gayam V Cureus; 2018 Sep; 10(9):e3331. PubMed ID: 30473964 [TBL] [Abstract][Full Text] [Related]
9. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio. Worasuwannarak S; Pornratanarangsi S J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554 [TBL] [Abstract][Full Text] [Related]
10. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. Chong E; Poh KK; Liang S; Tan HC Ann Acad Med Singap; 2010 May; 39(5):374-80. PubMed ID: 20535427 [TBL] [Abstract][Full Text] [Related]
11. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007 [TBL] [Abstract][Full Text] [Related]
12. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial. Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740 [TBL] [Abstract][Full Text] [Related]
13. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention. Chong E; Shen L; Poh KK; Tan HC Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288 [TBL] [Abstract][Full Text] [Related]
14. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI. Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G; Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668 [TBL] [Abstract][Full Text] [Related]
15. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography. Chen SQ; Liu Y; Smyth B; Li HL; Sun GL; Chen ZJ; Zhou YL Heart Lung Circ; 2019 Jun; 28(6):866-873. PubMed ID: 29960836 [TBL] [Abstract][Full Text] [Related]